Alexia V. Polissidis
CEO and Co-Founder
Anacalypsis Therapeutics
Precision therapeutics and biomarkers for Parkinson’s disease
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Anacalypsis Therapeutics is a Greek biotech developing disease-modifying treatments and early biomarkers for neurodegenerative diseases, with a focus on Parkinson’s disease. The company applies genetically linked targets and structure-based design to interfere with protein interactions and signaling pathways associated with neurodegeneration, and operates from the Athens LifeTech Park area.
- Website
- anacalypsistherapeutics.com
- Stage
- pre-seed
- Location
- Athens, Greece
- Added via
- web
- Ownership
- unclaimed
Where to go
Social profiles
Founders
Hardy J. Rideout
CSO and Co-Founder